PEGylated recombinant human insulin (Chongqing Fagen Biopharmaceutical)

N/A

Report date: 2025/03/20 15:04:00

Base Information

Drug NamePEGylated recombinant human insulin (Chongqing Fagen Biopharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInsulin receptor agonistsInsulin ligand
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChongqing Fujin Biological Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Fujin Biological Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A